文献速递鼻科

皮下免疫治疗不依从的危险因素与策略:一项真实世界研究

Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real-life study.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-07-26

该前瞻性研究纳入2012年1月至2014年1月接受标准化尘螨皮下免疫治疗的311例呼吸道过敏患者,通过每3个月电话访谈及网络社交应用在线沟通随访,记录停药原因。第3年依从率为64.6%,不依从原因包括不便(32.7%)、无效(25.5%)、症状改善(22.7%)和不良反应(14.5%);儿童依从率高于成人(70.7% vs 55.0%,p<0.05),且停药原因在儿童与成人组间不同(p<0.005)。

要点

  • 第3年依从率64.6%,近三分之一患者中断治疗。
  • 不依从主因为不便、无效、症状改善和不良反应。
  • 儿童依从率高于成人,停药原因组间有差异。

核心结论

  • 真实世界研究中皮下免疫治疗依从性欠佳。
  • 医患密切沟通有助于提高免疫治疗依从性。

研究设计与样本

  • 前瞻性研究,纳入2012年1月至2014年1月接受标准化尘螨皮下免疫治疗的呼吸道过敏患者311例。
  • 每3个月电话访谈及网络社交应用在线沟通随访,记录停药原因。

主要发现

  • 第3年依从率为64.6%。
  • 不依从原因:不便32.7%、无效25.5%、症状改善22.7%、不良反应14.5%。
  • 儿童依从率高于成人(70.7% vs 55.0%,p<0.05)。
  • 儿童与成人组停药原因不同(p<0.005)。

临床怎么用

  • 临床中应重视医患沟通以提升皮下免疫治疗依从性。
  • 针对儿童与成人不同停药原因采取相应管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allergen immunotherapy (AIT) is still the only causal treatment for allergic diseases. However, conventional subcutaneous immunotherapy (SCIT) administration schedules are time-consuming and patient nonadherence is a major barrier to achieving a satisfactory therapeutic effect. Our study aimed to analyze the causes leading to discontinuation of SCIT and to determine risk factors associated with nonadherence in respiratory allergies. METHODS: This was a prospective study. Patients with respiratory allergies who had received standardized dust mite SCIT were enrolled from January 2012 to January 2014. And a follow-up study on these subjects was conducted via telephone interviews on an interval of 3 months and online communication through social network applications. Reasons for discontinuation were documented when patients claimed to stop treatment. RESULTS: A total of 311 patients were enrolled in the study. The adherence rate at year 3 was 64.6%. Fifty-nine patients (19.0%) dropped out in year 1, 31 (10.0%) in year 2, and 20 (6.4%) in year 3. Reasons for nonadherence included inconvenience (32.7%), ineffectiveness (25.5%), improvement of symptoms (22.7%), and adverse reactions (14.5%). Children had higher adherence than adults (70.7% vs 55.0%) (p < 0.05). The dropout reasons were different among the children and adults groups (p < 0.005). The follow-up work was carefully and thoroughly done. All the 311 (100%) patients accepted the telephone interview, and 296 (95.2%) patients submitted questions and got rapid replies from doctors online. CONCLUSION: Adherence to SCIT was less than satisfactory in the real-life study. A close communication between doctors and patients is helpful in enhancing adherence with AIT in clinical practice.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Wang Y, Yang L, et al. Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real-life study. Int Forum Allergy Rhinol. 2018. PMID: 30048045. doi:10.1002/alr.22190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。